Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test
16 mai 2017 07h00 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, May 16, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the U.S. commercial launch of its Bordetella Direct Test...
Great Basin Scientific Receives FDA 510(k) Clearance for Bordetella Direct Test
03 avr. 2017 16h00 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, April 03, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, has received U.S. Food & Drug Administration (FDA) clearance for...
Great Basin Scientific Completes Clinical Trial, Submits FDA 510(k) Application for Bordetella Direct Test
01 févr. 2017 07h00 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the completion of the clinical trial and 510(k)...